Stay updated with breaking news from India Immunisation Programme. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Centre introduced several programmes in 2023, addressing the accessibility and affordability of the healthcare services. Here are some of the key initiatives taken by the government in 2023 to achieve its goal of ‘Health For All’
Updated Feb 15, 2021 | 19:36 IST Only days after beginning its own immunisation programme, India has wasted no time in embarking on a vaccine diplomacy drive that has already garnered plaudits from the international community. Representational image. | Photo Credit: PTI Key Highlights Via its 'Vaccine Maitri' initiative, India has sought to buttress ties with countries not just within its immediate radius, but beyond What makes this generosity even more remarkable is that it has arrived at a time when richer nations have opted to hoard vaccines under banne...
India wants Pfizer to do local study for Covid-19 vaccine approval Premium Krishna N. Das Any vaccine maker, including Pfizer, which has sought emergency-use authorisation for its Covid-19 shot in India, must conduct a local 'bridging' safety and immunogenicity study to be considered for the country's immunisation programme, a senior govt official said Share Via Read Full Story NEW DELHI : Any vaccine maker, including Pfizer Inc, which has sought emergency-use authorisation for its Covid-19 shot in India, must conduct a local "bridging" safety and immunogenicity study to be considered for the...
Govt wants Serum Institute to lower price of AstraZeneca shot: Report Premium (Photo: Mint) Neha Arora, , Reuters Senior officials have been discussing the terms of the deal with the Serum Institute for weeks, hoping to bring down prices below $3 per shot Share Via Read Full Story The Indian government has been negotiating with the Serum Institute of India to bring down the price of AstraZeneca's COVID-19 vaccine, people close to the matter said, delaying the roll-out of the country's immunisation programme. India's drug regulator has approved emergency use of the vaccine developed by Oxford...